George M. Jenkins's most recent trade in Palvella Therapeutics Inc. was a trade of 12,350 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palvella Therapeutics Inc. | George M. Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 12,350 | 12,350 | - | - | Non-Qualified Stock Option (right to buy) | |
| Palvella Therapeutics Inc. | George M. Jenkins | Director | Purchase of securities on an exchange or from another person at price $ 20.13 per share. | 09 Apr 2025 | 2,500 | 183,171 | - | 20.1 | 50,325 | Common Stock |
| Palvella Therapeutics Inc. | George M. Jenkins | Director | Purchase of securities on an exchange or from another person at price $ 20.27 per share. | 09 Apr 2025 | 2,490 | 13,516 | - | 20.3 | 50,472 | Common Stock |
| Palvella Therapeutics Inc. | M. Jenkins George | Director | Purchase of securities on an exchange or from another person at price $ 12.93 per share. | 18 Dec 2024 | 4,000 | 180,671 | - | 12.9 | 51,720 | Common Stock |
| Palvella Therapeutics Inc. | George M. Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2024 | 24,700 | 24,700 | - | - | Stock Option (right to buy) |